National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease

Jeffrey L. Winters, Leslie T Jr. Cooper, Nora R. Ratcliffe, Yanyun Wu, Patrick M. Moriarty

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well-designed research to address its efficacy. This article reviews the opportunities that were presented at this meeting in the area of cardiovascular disease (CVD), specifically the use of columns to adsorb autoantibodies in dilated cardiomyopathy or damaging lipids in peripheral vascular disease. Understanding how absorption of these pathologic substances alters the inflammatory response in these disorders is important for the application of these technologies to the treatment of CVD.

Original languageEnglish (US)
Pages (from-to)183-187
Number of pages5
JournalJournal of Clinical Apheresis
Volume30
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Blood Component Removal
Cardiovascular Diseases
Peripheral Vascular Diseases
Dilated Cardiomyopathy
Autoantibodies
Technology
Lipids
Therapeutics
Research

Keywords

  • Apheresis
  • Immunoadsorption
  • Lipid apheresis
  • Myocarditis
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Hematology

Cite this

National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease. / Winters, Jeffrey L.; Cooper, Leslie T Jr.; Ratcliffe, Nora R.; Wu, Yanyun; Moriarty, Patrick M.

In: Journal of Clinical Apheresis, Vol. 30, No. 3, 01.06.2015, p. 183-187.

Research output: Contribution to journalArticle

@article{4f29a08b54b7433d86ed70ba171983bd,
title = "National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease",
abstract = "The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well-designed research to address its efficacy. This article reviews the opportunities that were presented at this meeting in the area of cardiovascular disease (CVD), specifically the use of columns to adsorb autoantibodies in dilated cardiomyopathy or damaging lipids in peripheral vascular disease. Understanding how absorption of these pathologic substances alters the inflammatory response in these disorders is important for the application of these technologies to the treatment of CVD.",
keywords = "Apheresis, Immunoadsorption, Lipid apheresis, Myocarditis, Peripheral vascular disease",
author = "Winters, {Jeffrey L.} and Cooper, {Leslie T Jr.} and Ratcliffe, {Nora R.} and Yanyun Wu and Moriarty, {Patrick M.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1002/jca.21355",
language = "English (US)",
volume = "30",
pages = "183--187",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - National Heart, Lung, and Blood Institute State of the Science Symposium in therapeutic apheresis - Therapeutic apheresis in cardiovascular disease

AU - Winters, Jeffrey L.

AU - Cooper, Leslie T Jr.

AU - Ratcliffe, Nora R.

AU - Wu, Yanyun

AU - Moriarty, Patrick M.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well-designed research to address its efficacy. This article reviews the opportunities that were presented at this meeting in the area of cardiovascular disease (CVD), specifically the use of columns to adsorb autoantibodies in dilated cardiomyopathy or damaging lipids in peripheral vascular disease. Understanding how absorption of these pathologic substances alters the inflammatory response in these disorders is important for the application of these technologies to the treatment of CVD.

AB - The National Heart, Lung, and Blood Institute in collaboration with the American Society for Apheresis, convened a State of the Science Symposium in November of 2012 due to the expanding application of therapeutic apheresis despite the lack of well-designed research to address its efficacy. This article reviews the opportunities that were presented at this meeting in the area of cardiovascular disease (CVD), specifically the use of columns to adsorb autoantibodies in dilated cardiomyopathy or damaging lipids in peripheral vascular disease. Understanding how absorption of these pathologic substances alters the inflammatory response in these disorders is important for the application of these technologies to the treatment of CVD.

KW - Apheresis

KW - Immunoadsorption

KW - Lipid apheresis

KW - Myocarditis

KW - Peripheral vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84930850024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930850024&partnerID=8YFLogxK

U2 - 10.1002/jca.21355

DO - 10.1002/jca.21355

M3 - Article

C2 - 25181584

AN - SCOPUS:84930850024

VL - 30

SP - 183

EP - 187

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -